New research suggests that a combination of lung-sparing surgery, highly targeted radiotherapy, and chemotherapy may bolster survival in people with malignant pleural mesothelioma. Researchers at Memorial Sloan Kettering Cancer Center in New York have just published some promising findings on trimodality mesothelioma treatment with hemithoracic intensity-modulated pleural radiotherapy (IMPRINT). Conventional RT vs IMPRINT The team analyzed the cases of 209 mesothelioma patients who underwent the … Continue reading Tri-Modality Treatment Extends Mesothelioma Survival
Peritoneal mesothelioma patients whose bodies produce too many blood platelets may not be good candidates for the treatment combination known as CRS with HIPEC. Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a process for removing as much peritoneal mesothelioma from the abdomen as possible and killing any cancer cells left behind with a wash of heated medication. It has become the preferred … Continue reading Platelet Count Linked to Peritoneal Mesothelioma Survival After Surgery
New research out of Canada suggests that mesothelioma tumor thickness could be used to help predict mesothelioma survival and select the best treatments. Doctors at the University of Toronto compared the thickness of pleural mesothelioma tumors in 65 patients who had not yet received any treatment with their eventual outcomes and found a definite correlation. Summarizing their research in The European Respiratory Journal, the team … Continue reading Mesothelioma Tumor Thickness May Help Predict Treatment Outcomes
Pleural mesothelioma patients who undergo pleurectomy/decortication (P/D) surgery may need customized rehabilitation strategies to help restore their quality of life. That is the finding of a Japanese study conducted by rehabilitation experts at the Hyogo College of Medicine. In a study of malignant pleural mesothelioma patients, the team found that, after P/D, many measures of physical strength and vitality decreased, along with their health-related quality … Continue reading Mesothelioma Patients May Need Special Help After Surgery
There is new evidence that a mesothelioma patient’s nutritional status could have an impact on their treatment outcomes. A group of Japanese surgeons, oncologists and pathologists compared the treatment responses of 83 patients with pleural mesothelioma and found that patients with the poorest nutritional status tended to have the poorest mesothelioma prognosis. Controlling Nutritional Status Score To reach their conclusion, the researchers used a tool … Continue reading The Impact of Nutritional Status on Mesothelioma Survival
The heads of a European working group charged with advising cardio-thoracic surgeons on the best ways to treat malignant pleural mesothelioma say the most radical and risky type of surgery is not clinically effective. Dr. Giuseppe Cardillo of Carlo Forlanini Hospital in Rome and Dr. Tom Treasure with University College London (author of the MARS mesothelioma surgery study) detail their conclusion in a Letter to … Continue reading Radical Mesothelioma Surgery Deemed Not “Clinically Effective”
Immunotherapy is an important emerging therapeutic strategy for several types of cancer, but the jury is still out on whether it will eventually be a viable approach for malignant pleural mesothelioma. In a newly-published special report on the immune checkpoint inhibitor tremelimumab, researchers at the University of Salford in the UK call the use of such drugs “largely questionable” for pleural mesothelioma treatment. Their concerns, … Continue reading Immunotherapy for Pleural Mesothelioma: Does it Work?
Japanese researchers have come up with a new method of controlling one of the most bothersome and life-limiting symptoms of late stage malignant mesothelioma – a buildup of fluid around the lungs called malignant pleural effusion. When fluid collects in the space between the layers of the pleural membrane around the lungs, it becomes more difficult for the lungs to expand properly. At this stage, … Continue reading Novel Technique Controls Pleural Effusion in Mesothelioma Patients
The compound that gives the spice turmeric its yellow color and pungent flavor is once again attracting the attention of mesothelioma researchers. Curcumin has been the subject of numerous mesothelioma studies. The latest one, conducted by scientists at the Department of Experimental Medicine at the University of Rome, finds that the compound has the power to not only kill mesothelioma cells in the lab, but … Continue reading Spice Compound Extends Mesothelioma Survival in Mice
Researchers in London have developed a new way of categorizing patients with advanced malignant mesothelioma that allows them to predict who will benefit the most from participation in a Phase I clinical trial. The Drug Development Unit at the Royal Marsden Hospital already uses a prognostic scoring system for cancer patients to determine which patients would be good candidates for Phase 1 clinical trials of … Continue reading Scoring Tool Helps Doctors Select Mesothelioma Patients for Clinical Trials
Get your free copy of
Surviving Mesothelioma Today!